Centre of Excellence: HORIBA Medical Collaborates with Suburban Diagnostics HORIBA Medical is a world leader in the Hematology market present in over 110 countries on all 5 continents, with internationally recognized instruments. Annually HORIBA is producing more than 7500 hematology instruments across the world. In addition, 6000 tons of corresponding reagents are produced annually. We are not just producing instruments but are well established and globally accepted for our unique automation solutions for high-end laboratories across the globe. HORIBA Medical joins hands with Suburban Diagnostics and established country’s first of its kind, Centre of Excellence at Mumbai, India. This centre of excellence will be one of the unique concept based model created by any IVD brand in India. The objective of this centre is to bring all kinds of technologies and their application under one roof, where various stake-holders can utilize, learn and upgrade their knowledge & learning about complete process and requirements related to laboratory diagnosis. This centre will not just provide testing services but will also help technologists, pathologists and hematologists to bring advancement in upcoming technologies, establish better processes and protocols for testing and bring better understanding among laboratory technologists. HELO (HORIBA Evolutive Laboratory Organisation) is a modern mélange of innovative design, robust manufacturing standards, undisputed efficiency, unflinching accuracy, standardization & bullet-proof patient data safety. Embedded with advanced technologies of Yumizen H2500/H1500 which are well-established with over 3 decades of unbeatable experience in Hematology diagnosis with highest analytical performances. Customers across the world are moving towards HELO automation workflows. Experiencing difference in capacity, efficiency and reliability on results. HELO is a promising answer to the constant evolution and changing work-flow of medical laboratories with increasing pressure from regulatory bodies and accreditation agencies to maintain quality and accuracy without any compromise. High-end laboratories have each step in the sample life-cycle from collection to dispatch of reports is automated, thus assuring testing of the highest quality. Automated checks and balances are introduced by our globally diverse team of engineers and clinical subject experts, that ensures utmost diagnostic accuracy and reliability of services desired. The solution not just addresses customers routine needs but also assist them in optimization of TAT, reconfiguration of floor space, and ease of reagent storage and minimized reagent wastage. P8000, a specially designed middleware platform acts as a brain of HELO that performs automatic validation based on bespoke configurable rules like sample re-run, reflux to confirm results of critical samples, smear preparation or performing Reticulocyte count. This also helps to save time and least human intervention leading to improved TAT. QC rules are also configurable and error free MIS reports. HELO comes along with HORIBA’s accreditation assistance program which has been developed in accordance with ISO:15189 certification. Unique automated slide preparation system (SPS) can easily smear and stain your sample with high throughput of at 120 slides per hour. SPS has a specially engineered flexibility to regulate staining protocols i.e. MCG, Wright or Wright Giemsa. Digitalization of slides with RBC & WBC sub-classification and an optional remote review software application and a body fluid additional application is an added functionality of choice available to its users. To sum up, HELO is a uniquely optimized amalgamation of artificial intelligence and digital technological advancement that has been predicted to play a major role in medical laboratories of the future where healthcare is going to be integrated providing maximum convenience to both diagnosed patients, as well as to those opting to get preventive check-ups. HELO is an unbeatable promising solution of future laboratories which needs to be backed up strongly without exception on automation and digital technologies that will enable clinicians and pathologists to spare more time with patients, allowing technology to do the routine operations.
In this ever advancing world of cell counters where does a small lab with a 3-part differential cell counter stand, that was my question to myself when I started with Micros 60. I thought okay this the best we got and made some observations over 1-year period. As we all must be aware plasmacytoid lymphocytes are quite characteristic for dengue patients(citation), so I tried sometimes to go retrospective in case of plasmacytoid lymphocytes in confirmed dengue patients and tried looking at flags of Micros, and I found consistent M2 G1 G2 flag in dengue cases with thrombocytopenia, after sometime I become confident of this flag and any patient with classical high grade fever , calf tenderness and raised sgot sgpt enzyme levels having this flag on CBC would make me smile like a magician on being sure that it is dengue and I will get plasmacytoid lymphocytes in smear. But these observations are not true for every case, as I also observed similar flags in leukaemia and cases of acute hepatitis as other people (citation), so I suggest that in country like ours which sees epidemics of dengue year after year incorporating this M2 G1 G2 flag in screening algorithm for dengue will help us in detecting more cases of dengue during outbreaks.
Follow-up of bedside testing for serum CRP and CBC has potential clinical and economic impacts on the management of patients having high dose therapy (HDT)